We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current OSTX market cap is 37.49M. The company's latest EPS is USD and P/E is N/A.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -630k | -780k | -2.44M |
| Net Income | -1.49M | -1.56M | -2.88M |
| Year End 31 December 2022 | 2021 | 2022 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 |
| Operating Income | -4.84M | -4.45M |
| Net Income | -7.51M | -6.38M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|
| USD (US$) | USD (US$) | ||
| Total Assets | 1.05M | 1.34M | 1.98M |
| Total Liabilities | 26.56M | 28.41M | 2.68M |
| Total Equity | -25.51M | -27.06M | -707k |
| Year End 31 December 2022 | 2021 | 2022 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 326k | 509k |
| Total Liabilities | 11.78M | 18.07M |
| Total Equity | -11.45M | -17.56M |
| Market Cap | 37.49M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 21.24M |
| Average Volume (1 week) | 553.87k |
| Average Volume (1 Month) | 2.35M |
| 52 Week Change | -55.88% |
| 52 Week High | 7.00 |
| 52 Week Low | 1.58 |
| Spread (Intraday) | 0.01 (0.56%) |
| Company Name | OS Therapies Incorporated |
| Address |
18 manassas drive middletown, delaware 197093802 |
| Website | https://www.ostherapies.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
